Thomas J. Degnan
- Hematology top 5%
- Oncology
- Genetics top 10%
- Public Health, Environmental and Occupational Health
- Surgery
- Co-authors
- Philip SchulmanDaniel R. BudmanVincent VinciguerraNataline B. KardonLora WeiselbergV. VinciguerraTsieh SunRichard E. Rosenfield
- Topics
- Acute Myeloid Leukemia Research (6 papers)Chronic Lymphocytic Leukemia Research (5 papers)Eosinophilic Disorders and Syndromes (4 papers)
- Cited by
- HematologyGeneticsOncology
- Partner nations
- United StatesSwitzerlandCanada
In The Last Decade
Thomas J. Degnan
31 papers receiving 392 citations
Peers
Comparison fields: 5 of 66
- Hematology 206
- Oncology 104
- Genetics 95
- Public Health, Environmental and Occupational Health 77
- Surgery 72
Countries citing papers authored by Thomas J. Degnan
This map shows the geographic impact of Thomas J. Degnan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas J. Degnan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas J. Degnan more than expected).
Fields of papers citing papers by Thomas J. Degnan
This network shows the impact of papers produced by Thomas J. Degnan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas J. Degnan. The network helps show where Thomas J. Degnan may publish in the future.
Co-authorship network of co-authors of Thomas J. Degnan
This figure shows the co-authorship network connecting the top 25 collaborators of Thomas J. Degnan. A scholar is included among the top collaborators of Thomas J. Degnan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas J. Degnan. Thomas J. Degnan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Stormwise: Integrating arboriculture and silviculture to create storm-resilient roadside forests | 0 |
| 2 | 4 | |
| 3 | 50 | |
| 4 | 18 | |
| 5 | Phase I trial of vinzolidine. | 7 |
| 6 | 13 | |
| 7 | 2 | |
| 8 | 30 | |
| 9 | 7 | |
| 10 | 1 | |
| 11 | 1 | |
| 12 | 12 | |
| 13 | 14 | |
| 14 | 25 | |
| 15 | 9 | |
| 16 | 30 | |
| 17 | 26 | |
| 18 | 1 | |
| 19 | 14 | |
| 20 | 17 |
About Thomas J. Degnan
Thomas J. Degnan is a scholar working on Hematology, Genetics and Rheumatology, having authored 33 papers that have together received 446 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Eosinophilic Disorders and Syndromes (4 papers). The work is most often cited by research in Hematology (206 citations), Genetics (95 citations) and Oncology (104 citations). Thomas J. Degnan has collaborated with scholars based in United States, Switzerland and Canada. Frequent co-authors include Philip Schulman, Daniel R. Budman, Vincent Vinciguerra, Nataline B. Kardon, Lora Weiselberg, V. Vinciguerra, Tsieh Sun, Richard E. Rosenfield, Z Currimbhoy and Timothy D. Moore. Their work appears in journals such as JAMA, Journal of Clinical Oncology and Annals of Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.